L. Kadouri

Most-cited papers

1. A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.

   H. Rennert, D. Bercovich, A. Hubert, D. Abeliovich +10 more

   2002American Journal of Human Genetics123 citations Open access

   Semantic Scholar

   Save

2. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.

   B. Nachmias, Y. Ashhab, Vered Bucholtz, O. Drize +5 more

   2003Cancer Research122 citations

   Semantic Scholar

   Save

3. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

   L. Kadouri, Z. Kote-Jarai, A. Hubert, F. Durocher +5 more

   2004British Journal of Cancer113 citations Open access

   Semantic Scholar

   Save

4. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations

   L. Kadouri, A. Hubert, Y. Rotenberg, T. Hamburger +4 more

   2007Journal of Medical Genetics97 citations Open access

   Semantic Scholar

   Save

5. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

   L. Kadouri, Df Easton, S. Edwards, A. Hubert +6 more

   2001British Journal of Cancer81 citations Open access

   Semantic Scholar

   Save

6. The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin

   I. Lazar, B. Yaacov, T. Shiloach, E. Eliahoo +6 more

   2009Journal of Virology72 citations Open access

   Semantic Scholar

   Save

7. Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy

   Amir Sonnenblick, L. Kadouri, L. Appelbaum, T. Peretz +3 more

   2011Cancer Biology & Therapy70 citations Open access

   Semantic Scholar

   Save

8. Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations

   L. Kadouri, M. Sagi, Y. Goldberg, I. Lerer +2 more

   2013Breast Cancer Research and Treatment56 citations

   Semantic Scholar

   Save

9. A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: A possible role of the Alu‐polyA tail in the evolution of the deletion

   Tie-Ling Wang, I. Lerer, Zehava Gueta, M. Sagi +3 more

   2001Genes, Chromosomes and Cancer48 citations

   Semantic Scholar

   Save

10. Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers

    L. Kadouri, Z. Kote-Jarai, D. Easton, A. Hubert +5 more

    2004International Journal of Cancer45 citations

    Semantic Scholar

    Save

11. Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients

    B. Nisman, T. Allweis, L. Kadouri, Bela Mali +4 more

    2012Clinical Chemistry and Laboratory Medicine44 citations

    Semantic Scholar

    Save

12. Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment.

    Y. Rottenberg, A. Grinshpun, I. Ben-Dov, Esther Oiknine Djian +2 more

    2021JAMA Oncology40 citations Open access

    Semantic Scholar

    Save

13. Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer

    Amir Sonnenblick, B. Uziely, H. Nechushtan, L. Kadouri +8 more

    2013Breast Cancer Research and Treatment36 citations

    Semantic Scholar

    Save

14. Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer

    N. Halpern, Amir Sonnenblick, B. Uziely, L. Divinsky +4 more

    2017International Journal of Cancer34 citations Open access

    Semantic Scholar

    Save

15. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer

    L. Kadouri, D. Bercovich, A. Elimelech, I. Lerer +10 more

    2007BMC Cancer34 citations Open access

    Semantic Scholar

    Save

16. Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

    M. Lotem, S. Merims, S. Frank, T. Hamburger +18 more

    2016Journal of Immunological Research32 citations Open access

    Semantic Scholar

    Save

17. The Clinical Effect of the Inhibitor of Apopotosis Protein Livin in Melanoma

    I. Lazar, R. Perlman, M. Lotem, T. Peretz +2 more

    2012Oncology30 citations

    Semantic Scholar

    Save

18. RNASEL Mutation Screening and Association Study in Ashkenazi and Non-Ashkenazi Prostate Cancer Patients

    A. Orr-Urtreger, A. Bar-Shira, D. Bercovich, N. Matarasso +8 more

    2006Cancer Epidemiology, Biomarkers and Prevention30 citations Open access

    Semantic Scholar

    Save

19. Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization.

    L. Kadouri, Y. Rottenberg, A. Zick, T. Hamburger +3 more

    2019Lung Cancer26 citations

    Semantic Scholar

    Save

20. Autologous Melanoma Vaccine Induces Antitumor and Self-Reactive Immune Responses That Affect Patient Survival and Depend on MHC Class II Expression on Vaccine Cells

    M. Lotem, A. Machlenkin, T. Hamburger, A. Nissan +8 more

    2009Clinical Cancer Research24 citations Open access

    Semantic Scholar

    Save

21. Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers

    L. Kadouri, Z. Kote-Jarai, A. Hubert, M. Baras +4 more

    2008British Journal of Cancer22 citations Open access

    Semantic Scholar

    Save

22. Recurrent TP53 missense mutation in cancer patients of Arab descent

    A. Zick, L. Kadouri, Sherri Cohen, Michael Frohlinger +9 more

    2017Familial Cancer20 citations

    Semantic Scholar

    Save

23. Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer

    A. Hubert, Bela Mali, T. Hamburger, Y. Rottenberg +3 more

    2008Familial Cancer17 citations

    Semantic Scholar

    Save

24. Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel

    T. Yablonski-Peretz, S. Paluch-Shimon, L. S. Gutman, Y. Kaplan +16 more

    2015Breast Cancer Research and Treatment16 citations

    Semantic Scholar

    Save

25. Mutation spectrum in HNPCC in the Israeli population

    Y. Goldberg, R. Porat, I. Kedar, Chen Shochat +12 more

    2008Familial Cancer16 citations

    Semantic Scholar

    Save

26. Absence of founder BRCA1 and BRCA2 mutations in coetaneous malignant melanoma patients of Ashkenazi origin

    L. Kadouri, M. Temper, T. Grenader, D. Abeliovich +3 more

    2008Familial Cancer15 citations

    Semantic Scholar

    Save

27. Genetic features of Lynch syndrome in the Israeli population

    Y. Goldberg, I. Barnes-Kedar, I. Lerer, Naama Halpern +11 more

    2015Clinical Genetics14 citations

    Semantic Scholar

    Save

28. The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancer.

    B. Nisman, O. Maimon, T. Allweis, L. Kadouri +3 more

    2013Anticancer Research14 citations

    Semantic Scholar

    Save

29. “High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis”

    Shay Shraga, A. Grinshpun, A. Zick, L. Kadouri +11 more

    2021Frontiers in Oncology13 citations Open access

    Semantic Scholar

    Save

30. Increased Proliferative Background in Healthy Women with BRCA1/2 Haploinsufficiency Is Associated with High Risk for Breast Cancer

    B. Nisman, L. Kadouri, T. Allweis, B. Maly +3 more

    2013Cancer Epidemiology, Biomarkers and Prevention13 citations

    Semantic Scholar

    Save

31. Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations

    H. Nechushtan, T. Hamburger, S. Mendelson, L. Kadouri +3 more

    2009BMC Cancer11 citations Open access

    Semantic Scholar

    Save

32. Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open‐label, Phase II Trial

    T. Safra, B. Kaufman, L. Kadouri, N. Ben-Baruch +4 more

    2017Clinical Breast Cancer10 citations

    Semantic Scholar

    Save

33. Thyroid Hormones and Morphological Features of Primary Breast Cancer

    A. Meirovitz, B. Nisman, T. Allweis, E. Carmon +4 more

    2021Anticancer Research9 citations

    Semantic Scholar

    Save

34. Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer

    B. Nisman, T. Allweis, E. Carmon, L. Kadouri +4 more

    2020Anticancer Research9 citations Open access

    Semantic Scholar

    Save

35. BRCA1/2 carriers and endocrine risk modifiers.

    R. Eeles, L. Kadouri

    1999Endocrine-Related Cancer9 citations Open access

    Semantic Scholar

    Save

36. Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants

    R. Bernstein-Molho, E. Friedman, I. Kedar, Y. Laitman +22 more

    2020Breast Cancer Research and Treatment8 citations

    Semantic Scholar

    Save

37. Oncotargets and Therapy Dovepress Clinical Course and Outcome of Patients with High-level Microsatellite Instability Cancers in a Real-life Setting: a Retrospective Analysis

    N. Halpern, Y. Goldberg, L. Kadouri, M. Duvdevani +3 more

    8 citations

    Semantic Scholar

    Save

38. Preoperative MRI for Evaluation of Extent of Disease in IDC Compared to ILC.

    E. Carmon, Talia Alster, B. Maly, L. Kadouri +2 more

    2022Clinical Breast Cancer7 citations

    Semantic Scholar

    Save

39. Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review

    N. Halpern, A. Grinshpun, B. Boursi, T. Golan +14 more

    2020OncoTargets and Therapy7 citations Open access

    Semantic Scholar

    Save

40. MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?

    T. Sella, Bar Simor, Yael Adler-Levy, B. Maly +2 more

    2023European Radiology6 citations

    Semantic Scholar

    Save

41. Genetic anticipation of breast cancer among BRCA1/BRCA2 mutation carriers: A retrospective study

    Aviya Kedmi, L. Kadouri, I. Sagy, T. Hamburger +3 more

    2022International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics6 citations Open access

    Semantic Scholar

    Save

42. Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review.

    Chen Makranz, S. Khutsurauli, Y. Kalish, Ruth Eliahou +3 more

    2017Molecular and clinical oncology6 citations Open access

    Semantic Scholar

    Save

43. Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations

    J. Arnon, M. Tabi, Y. Rottenberg, A. Zick +9 more

    2023Cancers5 citations Open access

    Semantic Scholar

    Save

44. Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes

    M. Maoz, M. Devir, Michal Inbar, Ziva Inbar-Daniel +13 more

    2019Scientific Reports5 citations Open access

    Semantic Scholar

    Save

45. Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancer

    Amir Sonnenblick, Y. Rottenberg, L. Kadouri, M. Wygoda +4 more

    2012Medical Oncology5 citations

    Semantic Scholar

    Save

46. Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast Cancer

    B. Nisman, T. Allweis, E. Carmon, L. Kadouri +4 more

    2021Anticancer Research4 citations Open access

    Semantic Scholar

    Save

47. SYK expression level distinguishes control from BRCA1-mutated lymphocytes

    T. Zahavi, A. Sonnenblick, Yael Shimshon, L. Kadouri +3 more

    2018Cancer Management and Research4 citations Open access

    Semantic Scholar

    Save

48. Defects in homologous recombination repair genes are associated with good prognosis and clinical sensitivity to DNA-damaging agents in pancreatic cancer: A case report.

    Amir Sonnenblick, A. Zick, M. Maoz, Sherri Cohen +3 more

    2018Molecular and clinical oncology4 citations Open access

    Semantic Scholar

    Save

49. BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization

    R. Yerushalmi, A. Pomerantz, Ron Lewin, S. Paluch-Shimon +8 more

    2024Breast Cancer Research and Treatment3 citations Open access

    Semantic Scholar

    Save

50. Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation

    Yonaton Zarbiv, Y. Wygoda, A. Grinshpun, T. Hamburger +6 more

    2022Oncology and Therapy3 citations Open access

    Semantic Scholar

    Save